News Majority of panelists on controversial new cholesterol guideline have current or recent ties to drug manufacturers BMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f6989 (Published 21 November 2013) Cite this as: BMJ 2013;347:f6989 Article Related content Metrics Responses Peer review Related articles Analysis Should people at low risk of cardiovascular disease take a statin? Published: 22 October 2013; BMJ 347 doi:10.1136/bmj.f6123 News New US prevention guidelines focus on overall risk of cardiovascular disease Published: 14 November 2013; BMJ 347 doi:10.1136/bmj.f6858 News US heart doctors defend new prevention guidelines Published: 20 November 2013; BMJ 347 doi:10.1136/bmj.f6957 Editor's Choice Cardiovascular risk guidelines and transparency Published: 22 November 2013; BMJ 347 doi:10.1136/bmj.f7022 Views & Reviews Electronic health records may threaten blinding in trials of statins Published: 20 August 2014; BMJ 349 doi:10.1136/bmj.g5239 Correction Correction Published: 11 August 2016; BMJ 354 doi:10.1136/bmj.i4441 See more US food manufacturer can say that eating yogurt reduces risk of type 2 diabetes, says FDA BMJ March 06, 2024, 384 q569; DOI: https://doi.org/10.1136/bmj.q569 Alaskapox: First human death from zoonotic virus is announced BMJ February 15, 2024, 384 q415; DOI: https://doi.org/10.1136/bmj.q415 Advances in diagnosis and treatment of bladder cancer BMJ February 12, 2024, 384 e076743; DOI: https://doi.org/10.1136/bmj-2023-076743 US states that ban abortion have had nearly 65 000 pregnancies from rape, data show BMJ January 26, 2024, 384 q223; DOI: https://doi.org/10.1136/bmj.q223 Therapeutic advances in rheumatoid arthritis BMJ January 17, 2024, 384 e070856; DOI: https://doi.org/10.1136/bmj-2022-070856 Cited by... Setting a research agenda for medical overuseFulltext PDF Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol GuidelinesFulltext PDF Abstract Electronic health records may threaten blinding in trials of statinsFulltext PDF Abstract